Enjoy complimentary customisation on priority with our Enterprise License!
The global endocrinology drugs market size is forecast to increase by USD 36.84 billion at a CAGR of 7.45% between 2023 and 2028. The market is experiencing significant growth due to the rising incidence of endocrine disorders, particularly diabetes management device and obesity. The association between obesity and endocrine disorders, such as diabetes and thyroid disorders, is a major driver for the market. Additionally, the patent expiry of major endocrinology drugs has led to an increase in competition and price erosion, creating opportunities for generic drug manufacturers. However, challenges such as stringent regulatory requirements and the high cost of research and development continue to pose significant hurdles for market growth. Despite these challenges, the market is expected to witness steady growth due to the increasing prevalence of endocrine disorders and the development of innovative treatments.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Therapy Area
7 Market Segmentation by Distribution Channel
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.